GlassScriptPhysician profile
Caitlin Bowen
NPI 1891175634
$3,275.96
in general payments reported to CMS, 2019-2025
24 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2023: $1,290 · 2024: $1,683 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,890 · Education: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,890.30 |
| Education | $256.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $715.71 | 2023-2024 | |
| Janssen Biotech, INC. | $335.18 | 2023-2024 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $317.50 | 2023-2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $287.70 | 2023-2024 | |
| Galderma Laboratories, L.P. | $281.68 | 2021-2025 | Dysport, Epsolay, Aklief |
| Dermavant Sciences, INC. | $260.50 | 2023-2024 | Vtama |
| Lilly USA, LLC | $255.46 | 2023-2024 | Olumiant, Taltz, Jardiance |
| Genzyme Corporation | $151.78 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $133.04 | 2023-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $94.99 | 2025 | |
| Pfizer INC. | $67.01 | 2023-2024 | |
| Amgen INC. | $58.43 | 2023-2024 | Otezla |
| Arcutis Biotherapeutics, INC. | $54.18 | 2024 | Zoryve |
| Ucb, INC. | $45.61 | 2023-2024 | Bimzelx, Cimzia |
| Bayer Healthcare Pharmaceuticals INC. | $34.82 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $28.52 | 2023-2024 | Opzelura |
| Novo Nordisk INC | $24.93 | 2023 | Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $22.29 | 2023 | Trintellix |
| Exact Sciences Corporation | $20.71 | 2023 | Cologuard Collection Kit |
| Organon LLC | $20.16 | 2024 | |
| Shield Therapeutics INC | $18.51 | 2023 | Accrufer |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.67 | 2024 | Arazlo, Cabtreo |
| Glaxosmithkline, LLC. | $16.61 | 2023 | Trelegy Ellipta |
| Ardelyx, INC. | $12.97 | 2023 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.